D. Avila

发表

NIH response criteria measures are associated with important parameters of disease severity in patients with chronic GVHD

S. Steinberg, A. Berger, S. Mitchell, 2014, Bone Marrow Transplantation.

Validation of the National Institutes of Health chronic GVHD Oral Mucosal Score using component-specific measures

S. Steinberg, K. Baird, S. Mitchell, 2014, Bone Marrow Transplantation.

Oral Chronic Graft-vs.-Host Disease Characterization Using the NIH Scale

S. Steinberg, K. Baird, S. Mitchell, 2012, Journal of dental research.

National Institutes of Health (NIH) Chronic GVHD Staging in Severely Affected Patients: Organ and Global Scoring Correlate with Established Indicators of Disease Severity and Prognosis

J. Shelhamer, J. Gea-Banacloche, K. Baird, 2013 .

Spiritual Well-Being in Long-Term Survivors with Chronic Graft versus Host Disease after Hematopoietic Stem Cell Transplant (HSCT)

S. Steinberg, S. Mitchell, S. Pavletic, 2012 .

Phase I Trial of Adoptive Cell Transfer with Mixed-Profile Type-I/Type-II Allogeneic T Cells for Metastatic Breast Cancer

S. Steinberg, B. Levine, C. June, 2011, Clinical Cancer Research.

Salivary gland involvement in chronic graft-versus-host disease: prevalence, clinical significance, and recommendations for evaluation.

D. Kleiner, S. Mitchell, J. Atkinson, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Strategies to improve long-term outcome in stage IIIB inflammatory breast cancer: multimodality treatment including dose-intensive induction and high-dose chemotherapy.

S. Steinberg, M. Bishop, D. Danforth, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Prospective phase II trial of montelukast to treat bronchiolitis obliterans syndrome after hematopoietic cell transplant and investigation into BOS pathogenesis.

S. Steinberg, Stephanie J. Lee, J. Gea-Banacloche, 2022, Transplantation and cellular therapy.

Costimulated tumor-infiltrating lymphocytes are a feasible and safe alternative donor cell therapy for relapse after allogeneic stem cell transplantation.

S. Steinberg, S. Pittaluga, B. Levine, 2012, Blood.

Imaging of subclinical haemopoiesis after stem-cell transplantation in patients with haematological malignancies: a prospective pilot study.

S. Vesely, P. Choyke, J. Havlicek, 2018, The Lancet. Haematology.

Clinical significance of autoantibodies in a large cohort of patients with chronic graft‐versus‐host disease defined by NIH criteria

S. Steinberg, K. Baird, E. Cowen, 2015, American journal of hematology.

National Institutes of Health chronic graft-versus-host disease staging in severely affected patients: organ and global scoring correlate with established indicators of disease severity and prognosis.

J. Shelhamer, S. Steinberg, J. Gea-Banacloche, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

NHANES III equations enhance early detection and mortality prediction of bronchiolitis obliterans syndrome after hematopoietic SCT

J. Shelhamer, S. Steinberg, S. Gadalla, 2014, Bone Marrow Transplantation.

Clinical laboratory markers of inflammation as determinants of chronic graft-versus-host disease activity and NIH global severity

S. Steinberg, M. Bishop, K. Baird, 2011, Leukemia.

Haploidentical related donor hematopoietic stem cell transplantation with post-transplantation cyclophosphamide for DOCK8 deficiency.

Thomas E. Hughes, H. Kong, S. Holland, 2016, The journal of allergy and clinical immunology. In practice.

Tandem hematopoietic stem cell transplant considerations in families with multiple siblings affected by DOCK8 deficiency

S. Pai, J. Whangbo, A. Freeman, 2022, Bone Marrow Transplantation.

Hematopoietic Cell Transplantation and Outcomes Related to Human Papillomavirus Disease in GATA2 Deficiency.

S. Holland, A. Hsu, C. Zerbe, 2021, Transplantation and cellular therapy.

Rippled skin, fasciitis, and joint contractures.

L. Yao, H. Malech, E. Cowen, 2008, Journal of the American Academy of Dermatology.

Predictors for Permanent Discontinuation of Systemic Immunosuppression in Severely Affected Chronic Graft-Versus-Host Disease Patients.

S. Steinberg, A. Im, K. Baird, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Interim Analysis of a Phase II Trial of Montelukast for the Treatment of Bronchiolitis Obliterans Syndrome After HSCT Reveals Immunobiology of Disease

J. Shelhamer, Stephanie J. Lee, J. Gea-Banacloche, 2013 .

Determinants of functional performance in long-term survivors of allogeneic hematopoietic stem cell transplantation with chronic graft-versus-host disease (cGVHD)

N. Leidy, K. Mooney, P. Palit, 2010, Bone Marrow Transplantation.

Achalasia in a Patient Undergoing Hematologic Stem Cell Transplant After Exposure to Tacrolimus

S. Pavletic, T. Heller, A. Ling, 2017, Mayo Clinic proceedings. Innovations, quality & outcomes.

Prevalence and determinants of fatigue in patients with moderate to severe chronic GvHD

S. Steinberg, A. Im, K. Baird, 2016, Bone Marrow Transplantation.

Spiritual well-being in long-term survivors with chronic graft-versus-host disease after hematopoietic stem cell transplantation.

S. Steinberg, A. Berger, S. Mitchell, 2010, The journal of supportive oncology.

A Panoply of Rheumatological Manifestations in Patients with GATA2 Deficiency

S. Holland, A. Hsu, J. Katz, 2020, Scientific Reports.

GATA2 Deficiency: Early Identification for Improved Clinical Outcomes.

S. Holland, N. Shah, D. Hickstein, 2019, Clinical Journal of Oncology Nursing.